Lv3
230 积分 2023-10-13 加入
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
1个月前
已完结
[Expert consensus on homologous recombination repair gene testing and variant interpretation in prostate cancer]
1个月前
已完结
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T‐Cell Engager, in Prostate Cancer Patients
1个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1个月前
已完结
PSMA-based therapeutics for prostate cancer
1个月前
已完结
Prostate Cancer Theranostics
1个月前
已完结
STEAP Proteins: Roles in disease biology and potential for therapeutic intervention
1个月前
已完结
Advances in Targeted Therapy for Metastatic Prostate Cancer
1个月前
已完结
Cell-surface targets for prostate cancer therapeutics
1个月前
已完结
STEAP1 as a potential target for new therapies in prostate cancer
1个月前
已关闭
皖公网安备34019202002308
